In essence, the purpose of immunotherapy is to re-awaken the immune system to allow the targeting of cancer cells for immune destruction, with ICIs that block PD-1 and PD-L1 being used to hinder the immune tolerance mechanism triggered by the PD-1/PD-L1 interaction. The gene discussed is CD274; the disease is cancer.